Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
This comparison highlights retirement index funds with the smallest fees, helping you choose cost-efficient options for a brighter retirement.
27,211 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Rubrik faces a pivotal Q1 print, with traders watching for signs of margin expansion and cash flow improvement after ...
Newmont faced a sharp one-day decline as gold trends shifted and market risks crept in. This article breaks down the ...
A director bought a sizable stake in VIA Transportation, prompting questions about the stock’s future. This guide bre...
Investors watched Alphabet slide as news of AI talent exits raised questions about leadership and the pace of AI inve...
Fresh data from Stanford and ADP shows AI exposure weighing on entry-level hiring, challenging hopes that automation ...
Archer Aviation rode the eVTOL thrill, but reality check milestones have tempered the hype. This guide helps you deci...
U.S. equities closed the second quarter with a double‑digit rally, led by AI-driven tech names. Yet analysts warn tha...
Supreme Court justices testified before a House panel seeking more security funding as threats against them grow. Bar...
SCPQ rose sharply as SpaceX slipped to fresh lows, underscoring daily-reset risks in leveraged inverse ETFs and the m...
In a choppy crypto market, Zcash faced a dramatic turn after its development team resigned amid board tensions. This ...
RedotPay, a hong kong-based stablecoin payments company, is weighing a U.S. IPO that could raise more than $1 billion...